Paroxetine in Parkinson's disease: Effects on motor and depressive symptoms

Neurology

Volumn 55, Issue 8, 2000, Pages 1216-1218

  Ceravolo, R ^a   Nuti, A ^a   Piccinni, A ^a   Dell'Agnello, G ^a   Bellini, G ^a   Gambaccini, G ^a   Dell'Osso, L D ^a   Murri, L ^a   Bonuccelli, Ubaldo ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; FLUOXETINE; FLUVOXAMINE; LEVODOPA; PAROXETINE; PRAMIPEXOLE; ROPINIROLE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DEPRESSION; DRUG EFFECT; FEMALE; HAMILTON SCALE; HUMAN; MALE; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; PARKINSON DISEASE; PRIORITY JOURNAL; SCORING SYSTEM; TREMOR;

EID: 0034711133     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.55.8.1216     Document Type: Article

References (10)

1. Movement disorders associated with the serotonin selective reuptake inhibitors
2. A case of Parkinson's disease exacerbated by fluoxetine
3. Increase of Parkinson disability after fluoxetine medication
4. Worsening of parkinsonism with fluvoxamine: Two cases
5. Parkinsonism exacerbated by paroxetine
6. Does fluoxetine exacerbate Parkinson's disease?
7. Does fluoxetine aggravate Parkinson's disease? A pilot prospective study
8. Do serotonin reuptake inhibitor antidepressants worsen Parkinson's disease? A retrospective case series
9. Sertraline for the treatment of depression in Parkinson's disease
10. Systematic review and guide to selection of selective serotonin reuptake inhibitors